Research
On-going
-
Computational and experimental discovery of new biotherapeutics against cytotoxin.
-
Discovery of aptamer as toxin-neutralisation molecule.
-
Environmental toxin monitoring toolkit.
-
Repurposing venom-derived peptides as combatants against antibiotic resistance.
-
Epitope characterisation and mapping of venom cytotoxin to develop next-generation toxin targeted biotherapeutics.
-
Pharmacophore-based design of cationic cell-penetrating peptides derived from cytotoxin as antimicrobial molecules.
-
Pharmacophore modelling based inhibitor selection of cytotoxin towards the discovery of novel therapeutics for dermonecrosis.
-
Next-generation aptamer-based biotherapeutics as antivenom and antimicrobial agent in envenomation.
Completed
-
MELD-mass spectrometry approach in functional epitope mapping of cobra venom cytotoxin.
-
Experimental and computational approach to reveal the fundamental insights into the mechanisms of cytotoxicity for cobra cytotoxins.
-
Unravelling the mechanisms of cytotoxin-induced transition of cell death pattern using proteomics approach.
-
IoT and Industry 4.0: A rapid tool to bio-prospect microalgae with wound healing properties.
-
Technology Surveillance of Microalgae Blooms at Freshwater: The Next-generation Discovery of Sustainable Resources.
-
Purification, gene cloning, and expression of cytotoxin in mammalian expression vectors.
Bioinformatics and computational research
-
Ensemble-based virtual screening of death receptors with cytotoxin using molecular dynamic and molecular docking
-
Physicochemical and domain architecture of cytotoxin.
-
Molecular dynamic simulation of cytotoxin with membrane.
-
Immunoinformatics analysis.
-
High-throughput virtual screening (HTVS) and pharmacophore modeling